In the current study, we demonstrated that CM from an HCC cell line that was engineered to overexpress WISP2 significantly inhibited proliferation of LX2, and after downregulation of HMGB1 in these cells, an additional significant decrease in proliferation was observed. This evidence concerns the gene HMGB1 and hepatocellular carcinoma.